Medtronic Announces U.S. Trial Of Separate Therapy For Closure Of The Left Atrial Appendage
/* 468x60, */
Medtronic, Inc. (NYSE: MDT) announced the successful implant of its Cardioblate Closure Left Atrial Appendage Occlusion Slogan by Dr. Patrick McCarthy, co-director of the Bluhm Cardiovascular Institution at Northwestern Memorial Infirmary in Chicago, Ill., as part of a U.S. clinical trial. The study is duration conducted under an Investigational Device Exemption (IDE) and the device is community to investigational use in the United States.
Published literature suggests that the left atrial appendage (LAA) is the leading source of clots coming from the left atrium. Patients with an arrhythmia known as atrial fibrillation (AF) admit an increased risk of clot formation as a result of the uncoordinated and fast beating of the heart's upper chambers, which may facade to blood pooling in the LAA. AF is a recognized independent risk circumstance for stroke and encompassing 35 percent of patients with this irregular feelings rhythm will have a stroke during their lifetime.
The trial involves five U.S. centers and will evaluate occlusion of the left atrial appendage with the Cardioblate Closure device in patients undergoing valve replacement, valve repair or coronary bypass surgery.
Dr. Patrick McCarthy, the clinical trial's principal investigator, said, "The clinical limited urgently needs defended and proven therapies to achieve permanent closure of the left atrial appendage. Designed to enable elementary positioning for protected and the works occlusion of the left atrial appendage, this new device shows appreciable promise."
Unlike competitor alternatives, Medtronic's Cardioblate Closure device is intended to occlude the LAA permanently without the extremity to enter the heart and does not introduce man-made materials into the blood stream. It is designed to be pliable and atraumatic to ensure no collateral damage to surrounding structures of the heart, unlike rigid epicardial occlusion devices.
/* 468x60, */
Last relative articles:
- Use Of Statins Increases The Risk Of Developing Type 2 Diabetes But Reduces Coronary Events
- Heart Failure Worse When Right Ventricle Goes Bad
- Cooling Inflammation For Healthier Arteries
- Experts Identify Why Women And African Americans Face A Greater Risk Of Dying From Heart Disease Than White Men And What Can Be Done About It
- New Book Helps Pharmacists Play Larger Role In Heart Health
- Novel Screening Technique Identifies New Effects Of Approved Drugs For Cardiovascular Disease
- Compound Shows Promise Against Intractable Heart Failure
- Researchers Find Air Pollution Linked To Progression Of Atherosclerosis
- Heart-Assist Device Helped Ready 16-Year-Old For Successful Surgery
- Seven Signs That May Warn Of A Rare Heart Condition
atrial, atrial appendage, left atrial, atrial fibrillation, arrhythmia atrial